Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NanoDel Technologies

NanoDel Technologies?uq=PEM9b6PF
2003 FOUNDED
M&A STATUS
Merger of Eq. LATEST DEAL TYPE
Description

Researcher and developer of drug carrier systems. The company develops nanoparticle based technology to deliver compounds that are suitable for the treatment of brain tumors and other acute and chronic CNS related disorders, such as brain infections, neuroprotection, epilepsy, Alzheimer's disease and others.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Acquirer
Capsulution Pharma
Primary Office
  • Leipziger Straße 44 (ZENIT)
  • 39120 Magdeburg
  • Germany
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NanoDel Technologies’s full profile, request a free trial.

NanoDel Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger of Equals 17-Nov-2008 00.000 Completed Generating Revenue
3. Angel (individual) 01-Dec-2006 00.000 00.000 Completed Startup
2. Angel (individual) 01-Jun-2005 $1.21M Completed Startup
1. Seed Round 01-Jun-2004 $1.21M $1.21M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NanoDel Technologies Executive Team (3)

Name Title Board
Seat
Contact
Info
Karim Balan Ph.D Interim Chief Executive Officer & Co-Founder
Hans-Eckart Radunz Co-Founder
Joachim Bender Ph.D Chief Executive Officer